These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ribavirin aerosol treatment of influenza B virus infection.
    Author: McClung HW, Knight V, Gilbert BE, Wilson SZ, Quarles JM, Couch RB, Divine GW, Gordon WH, Thurston JM, Atmar RL.
    Journal: Trans Assoc Am Physicians; 1983; 96():284-93. PubMed ID: 6093312.
    Abstract:
    In a randomized, controlled study, ribavirin small particle aerosol was found to be effective in the treatment of influenza B virus infection in a group of college students. Eleven treated patients experienced significantly more rapid defervescence, disappearance of systemic illness, and reduction of virus shedding in nasal secretions than 10 control patients treated with a saline aerosol. Antibody response to infection was similar in both groups. The treatment was well tolerated and hematologic and clinical chemical tests revealed no toxicity. The estimated dose of ribavirin aerosol retained was about 2 g in 35.5 hr of treatment during the first 60 hr in the hospital.
    [Abstract] [Full Text] [Related] [New Search]